In this week’s DeviceTalks Weekly podcast, we visit with Chris Landon, senior vice president and business leader of image guided therapy devices at Philips about that company’s plans to build a medtech powerhouse. In this conversation we’ll learn: Why Landon left Medtronic Where Philips fits into medtech’s future How Philips hopes to expand Will Philips […]
Special Content
DTW Podcast: Who will win medtech’s own Supreme Court fight; and can the many mini Medtronics plan work?
In this week’s DeviceTalks Weekly podcast, we’ll first delve into Medtech’s own brewing Supreme Court battle. J. Michael Jakes, a partner at Finnegan, will tell us why the industry should be watching when the Supremes review the latest patent battle between Arthrex and Smith+Nephew. We’ll also talk about Medtronic’s Analyst Meeting where CEO Geoff Martha […]
DTW Podcast: Smith+Nephew’s Ortho president, Rhaeos’ big win and Medtronic’s legacy
In this week’s DeviceTalks Weekly Podcast, our opening and closing keynote interviews focus on executives from companies at very different stages. Manufacturing and sourcing Skip Kiil took the helm of Smith+Nephew’s (NYSE:SNN) global orthopedics business to transform it. The company’s recent acquisition of Integra LifeSciences’ (NSDQ:IART) extremities business will further that mission. In our closing keynote conversation, […]
DTW Podcast: New tools helping medtechs overcome COVID19 challenges
In this week’s DeviceTalks Weekly Podcast, senior executives from Avail Medsystems and AliveCor detail how their tools are helping medtechs remain in contact with both physicians and patients. In the keynote interview with Daniel Hawkins, CEO of Avail Medsystems, says the company’s Procedural Telemedicine system will allow medical device sales representatives to observe more procedures […]
DTW Podcast: Can Boston Scientific close the gap?
Following the killing of George Floyd in June, medtech companies stood strongly against inequality and racism and promised to push for change. Boston Scientific’s executive committee, including CEO Michael Mahoney, issued one of the earliest statements to condemn “injustice and discrimination and to reaffirm our commitment to live by our values and cultivate a workplace […]
DTW Podcast: KCK’s Long says deals getting done during COVID era
In this week’s DeviceTalks Weekly Podcast, Karen Long, managing director at KCK Group, says startups looking for funding have an opportunity to catch the eye and ear of investors. KCK, an active medtech investor, has been involved in two sizable investments this summer including Aerin Medical and NeuroPace. Both were portfolio companies, but Long says […]
DTW Podcast: Truist’s Kaila Krum says Medtronic prepping for growth
In an interview with DeviceTalks Weekly Podcast, Truist Securities managing director Kaila Krum says Medtronic executives are retooling the company to keep pace with smaller, more focused competitors. Breaking down the company’s Q1 call, Krum says Medtronic is seen as a company that’s too big to grow market share quickly. On the call, new CEO […]
DTW Podcast: Can Fractyl Labs and Cala Health go where only drugs have gone before?
In this week’s DeviceTalks Weekly podcast, co-costs Tom Salemi and Chris Newmarker walk through this week’s “Newmarker’s Newsmakers,” the Top Five #medtech stories of the week with news coming from CureVac, Avail Medsystems, ClearMask, Thermo Fisher and Bayer. We also hear from CEO Harith Rajagopalan, MD and CFO Lisa Davidson of Fractyl Laboratories, which is […]
DTW Podcast: Vizient on PPE, Vicarious on VR-aided robotics and let’s all hope for pumpernickel
This week’s episode of DeviceTalks Weekly is brought to you by the later V, as in Vizient and Vicarious Surgical. Bharat Sundaram, COO and president of Vizient, will share how the healthcare supplier is strengthening the supply of PPE for hospitals. He’ll also reveal when the company expects to see US hospitals running at pre-COVID […]
DTW Podcast: 10 ways medtech is finding its footing amid COVID-19
When COVID-19 set upon the U.S. in March, medtech executives had a month at most to tell Wall Street analysts how the pandemic had hit the industry’s largest companies. We heard about short-term hits in revenues, procedures and employee headcounts, but uncertainty clearly ruled the day. Over the past few weeks, medtech executives from several […]
DTW: What in the world will Thrive Earlier Detection do with $257 million?
In this week’s podcast, two executives from Thrive Earlier Detection explain how the “turbo-charged” diagnostics company intends to upend how, when and where cancer is diagnosed. Dr. Isaac Kinde, co-founder and head of research and innovation, walks us through the company’s CancerSEEK test and how the company is marrying new technology with an innovative clinical […]